Market revenue in 2023 | USD 15,708.7 million |
Market revenue in 2030 | USD 28,949.5 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Conventional drugs (small molecules) |
Fastest growing segment | Biologics & Biosimilars (Large Molecules) |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules) |
Key market players worldwide | Roche Holding AG ADR, Novartis AG ADR, GlaxoSmithKline, Pfizer Inc, Merck & Co Inc, AstraZeneca PLC, Johnson & Johnson, Sanofi SA, Eli Lilly and Co, AbbVie Inc, Thermo Fisher Scientific Inc, Wuxi AppTec Co Ltd, Samsung BioLogics, FUJIFILM Holdings Corp, Lonza Group Ltd, Catalent Inc, Jubilant Pharmova |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical manufacturing market will help companies and investors design strategic landscapes.
Conventional drugs (small molecules) was the largest segment with a revenue share of 61.43% in 2023. Horizon Databook has segmented the Latin America pharmaceutical manufacturing market based on biologics & biosimilars (large molecules), conventional drugs (small molecules) covering the revenue growth of each sub-segment from 2018 to 2030.
Persistent inequities in the distribution of wealth, coupled with social exclusion, can impact outcomes in the healthcare industry. Brazil is considered a key contributor to the Latin American market growth, followed by Mexico.
The region is experiencing several developments in the pharmaceutical manufacturing market despite diverse & complex demographics, complex reimbursement regulations, and a dynamic political environment.
Acknowledging these shortcomings, standardization of pharmaceutical regulations has been initiated, along with the development of regional free-trade zones. These initiatives are expected to propel the regional pharmaceutical manufacturing market.
Increasing government spending, growing investments by major pharmaceutical & biopharmaceutical companies, and the presence of major academic research institutes are factors likely to promote market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America pharmaceutical manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America pharmaceutical manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account